Article Details
Retrieved on: 2021-06-16 19:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The drug candidate AADvac1, made by biotech company Axon Neuroscience, was shown to be safely tolerated by patients and produced high levels ...
Article found on: m.washingtontimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here